India 80 Percent Through Testing Drug Samples For Counterfeits
This article was originally published in PharmAsia News
Executive Summary
India's Drug Controller General says the agency has collected 31,500 samples of drugs in its quest to determine which may be evading price regulations. The director of the agency said DCGI intends to enforce a new law that imposes stringent penalties on changes in drug compositions without its approval. Dr. Surinder Singh said some companies are evading price controls by retaining the brand name of the drugs after removing the active pharmaceutical ingredient subject to controls. State drug inspectors who collected the samples have examined about 80 percent of them in detail to determine which may be in violation. A report is expected to be issued in December. (Click here for more